TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression
- 1 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Protoplasma
- Vol. 257 (3), 921-930
- https://doi.org/10.1007/s00709-020-01480-6
Abstract
The present study aims to investigate the roles of TCF4 and its underlying mechanism in colorectal cancer (CRC). Doxorubicin-resistant DLD-1 (DLD1 DR), TCF4 overexpression, and TCF4 knockdown cell lines were constructed. A flow cytometer was used to analyze frequencies of CD133(+) cell in the DLD1 and DLD1 DR cells. Quantitative real-time PCR (qPCR) was used to determine the expressions of cancer stem cell (CSC) makers. Stemness of CRC cells were determined using tumorsphere formation assay. The correlation between TCF4 and ZEB1/ZEB2 were determined using public data from The Cancer Genome Atlas (TCGA) datasets. ZEB1/ZEB2 overexpression cell lines were constructed and cell viabilities were then determined using MTT and colony formation assays. TCF4 overexpression promoted proliferation of CRC cell lines and relative expressions of TCF4 were significantly increased in the DLD1 DR cells. TCF4 overexpression promoted CRC cell doxorubicin resistance, whereas TCF4 knockdown significantly decreased doxorubicin resistance. Additionally, TCF4 overexpression also significantly increased frequencies of CSC cells, expressions of CSC markers, and CRC ability to form tumorsphere. Furthermore, TCF4 promoted ZEB1 and ZEB2 expression, leading to CRC proliferation and doxorubicin resistance. TCF4 promoted CRC doxorubicin resistance and stemness by regulating expressions of ZEB1 and ZEB2.Keywords
This publication has 27 references indexed in Scilit:
- Krüppel-Like Factor 4 Acts as an Oncogene in Colon Cancer Stem Cell-Enriched Spheroid CellsPLOS ONE, 2013
- Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal TransitionJournal of Biological Chemistry, 2011
- Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell–Like Properties and Epithelial–Mesenchymal TransdifferentiationCancer Research, 2010
- Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosisCancer Science, 2009
- A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in CancerClinical Cancer Research, 2009
- Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following ChemotherapyPLOS ONE, 2008
- Phenotypic characterization of human colorectal cancer stem cellsProceedings of the National Academy of Sciences, 2007
- Mutations in TCF4, Encoding a Class I Basic Helix-Loop-Helix Transcription Factor, Are Responsible for Pitt-Hopkins Syndrome, a Severe Epileptic Encephalopathy Associated with Autonomic DysfunctionAmerican Journal of Human Genetics, 2007
- Drug resistance, predictive markers and pharmacogenomics in colorectal cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006
- Cancer Stem CellsPublished by Wiley ,2006